Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin ODT vs placebo for sleep behaviour and daytime performance in nocturia
2012-004388-34Phase 2Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jan 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nocturia comparing Desmopressin ODT with Placebo (2 arms). Primary endpoints: Sleep behaviour and Daytime performance. Started Jan 2013; status: terminated.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on 2012-004388-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004388-34.